NCT04076683View on ClinicalTrials.gov

Algorithm for Apherisis Monitoring and Prescription Assistance in Sickle Cell Patients (ALGODREP)

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Sickle Cell Disease
Interventions
DEVICE

Algodrep

Algorithm computing the volume of blood to be transfused and the interval between apheresis which are necessary to maintain an individual objective of HbS percentage.

Trial Locations (8)

25000

Centre de Santé EFS, Besançon

33035

Centre de Santé EFS, Bordeaux

35016

Centre de Santé EFS, Rennes

37206

Centre de Santé EFS, Tours

42277

EFS Rhône-Alpes-Auvergne, Saint-Priest-en-Jarez

94010

Hôpital Henri Mondor, Créteil

94270

CHU Kremlin Bicêtre, Le Kremlin-Bicêtre

97232

CHU de Martinique, Le Lamentin

All Listed Sponsors
collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

collaborator

Paris 12 Val de Marne University

OTHER

lead

Etablissement Français du Sang

OTHER

NCT04076683 - Algorithm for Apherisis Monitoring and Prescription Assistance in Sickle Cell Patients (ALGODREP) | Biotech Hunter | Biotech Hunter